Insider trades

Scilex, 10% Owner of Semnur Pharmaceuticals SMNR, has filed 0 purchases and 2 sales on the open market. The latest trade was on 06/15.

Scilex

10% Owner
First filing
25/09/25
Trades
3 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
06/15

Trading activity

Transactions

Trade type
SMNR
Open-market sale25/09/2325/09/2512,500,000 sh2 trades$16.00avg.$200,000,000No record